The highly infectious measles virus is one of the most contagious or all diseases, which spreads through airborne particles when the infected person breathes, coughs, or sneezes. These particles can remain infectious in the air for up to two hours after an infected person leaves an area.
Following decades of high vaccination rates with the measles, mumps, and rubella (MMR) vaccine, measles was declared eliminated in the US in 2000. However, falling vaccination levels in recent years have opened the door to a resurgence of measles outbreaks, such as are currently being seen in Texas and New Mexico. Already the total number of measles cases in the US in 2025 has exceeded the total for all of 2024 by 33 percent.
According to the CDC, “There have been 3 outbreaks (defined as 3 or more related cases) reported in 2025, and 90% of confirmed cases (341 of 378) are outbreak-associated. For comparison, 16 outbreaks were reported during 2024 and 69% of cases (198 of 285) were outbreak-associated“.
Because of the suddenness with which this virulent respiratory infection can overwhelm hospitals, especially smaller facilities in rural areas, it is critical to have front line protection measures in place to stem the spread and protect both patients and medical staff.
SafER portable respiratory isolation systems provide an important and quick-to-deploy solution for battling the spread and impacts of respiratory disease outbreaks, such as the current measles resurgence. SafER has been shown to provide 99% effectiveness in removing exhaled particles from the environment.
In addition to being key to managing respiratory disease outbreaks like measles, SafER delivers long term value through cost effective infection control, reduced staff absences due to illness, enhanced and more timely patient outcomes. This reduces the risk of exposure for workers in high risk situations and helps maintain operational continuity.
For hospitals and medical care organizations that have already adopted SafER portable systems as a part of their ongoing operations, the ability to redeploy them in response to unexpected respiratory outbreaks is now a key element in rapid-response plans.
In the interest of public health, SafER also stands ready to provide rapid-ship prioritization for hospitals and
organizations that are facing emergent outbreaks, such as many are now experiencing with measles.
For more information on SafER, or to learn about our rapid deployment capabilities, Contact Us Here